세계의 말 헬스케어 시장 보고서(2025년)

Equine Healthcare Global Market Report 2025

US $ 4,490 ￦ 6,371,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,209,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 12,048,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

말 헬스케어 시장 규모는 향후 몇 년동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 연평균 6.4%의 성장률로 19억 1,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 유전자 검사 및 개인 맞춤형 의료, 말의 웰빙 프로그램, 승마 이벤트의 세계화, 인수공통전염병 대비, 반도핑 규제에 대한 대응 등에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 원격 의료 및 원격 모니터링 솔루션, 말용 웨어러블 기술, 말 재활 및 물리치료, 말 치과 치료 및 치과 서비스, 약초 및 대체 요법 등이 있습니다.

동물 건강관리에 대한 인식이 높아짐에 따라 말 건강관리 시장의 성장이 예측 기간 동안 촉진될 것으로 예상됩니다. 생태계에서 동물의 중요한 역할에 대한 인식이 높아지면서 동물의 건강은 동물 자신의 안전과 행복뿐만 아니라 인간의 건강에도 필수적이라는 인식이 확산되고 있습니다. 동물이 앓고 있는 질병은 사람에게 쉽게 전염될 수 있기 때문에 각국 정부와 민간단체는 동물 건강관리 인프라 개발에 투자할 것을 촉구하고 있습니다. 예를 들어, 2023년 2월 영국의 데이터 분석 및 조사 기관인 Euromonitor International Ltd.의 조사에 따르면, 매일 또는 거의 매일 반려동물을 치료하는 빈도가 2021년 26%에서 2023년 29%로 증가했습니다. 소비자들은 기호품보다 건강을 우선시하고, 영양가 있고 기능적인 간식을 찾고 있습니다. 이에 따라 동물 건강 관리에 대한 인식이 높아지면서 예측 기간 동안 시장 확대에 기여할 것으로 보입니다.

말 헬스케어 시장은 인수공통전염병 증가로 인해 성장이 가속화될 것으로 예상됩니다. 이러한 감염은 바이러스, 박테리아, 기생충, 곰팡이 등의 병원체에 의해 발생하며, 동물과 사람 사이에 감염될 수 있습니다. 말 헬스케어 시장의 확대는 인수공통전염병의 발생이 증가함에 따라 말 소유주들이 동물의 예방 조치와 건강 관리를 우선시하게 된 데 기인합니다. 이러한 추세에 박차를 가하는 것은 인수공통전염병과 관련된 위험에 대한 인식 증가와 수의학적 제품 및 서비스의 도입 확대입니다. 예를 들어, 스웨덴에 본부를 둔 정부 기관인 유럽질병예방관리센터의 보고서에 따르면 2022년 12월 캄필로박터증은 여전히 가장 유행하는 인수공통전염병으로 2022년에 127,840건의 사례가 보고될 것으로 예상했습니다. 캄필로박터증 환자의 주요 보고된 주요 원인은 닭고기와 칠면조 고기인 것으로 확인되었습니다. 살모넬라균은 두 번째로 많은 인수공통전염병으로 60,050명이 발병했습니다. 캄필로박터증, 살모넬라증에 이어 엘시니증(6,789건), 시가톡신 생산 대장균 감염증(6,084건), 리스테리아증(2,183건)이 가장 많이 보고된 인수공통전염병이었습니다. 결과적으로 말 헬스케어 시장의 성장은 인수공통전염병 발생 건수 증가가 주도하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계마 헬스케어 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
• 최종 이용 산업 분석
• 세계의 말 헬스케어 시장 : 성장률 분석
• 세계의 말 헬스케어 시장 실적 : 규모와 성장, 2019-2024
• 세계의 말 헬스케어 시장 예측 : 규모와 성장, 2024-2029, 2034F
• 세계마 헬스케어 TAM(Total Addressable Market)

제6장 시장 세분화

• 세계의 말 헬스케어 시장 : 제품별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• Epoetin-alfa
• Epoetin-beta
• Darbepoetin-alfa
• 기타 제품
• 세계의 말 헬스케어 시장 : 약제 클래스별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• Biologist
• Biosimilar
• 세계의 말 헬스케어 시장 : 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 암
• 혈액학
• 신장질환
• 신경학
• 기타 용도
• 세계의 말 헬스케어 시장 : Epoetin-alfa별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• Epoetin-Alfa
• Epoetin-Alfa Biosimilars
• 세계의 말 헬스케어 시장 : Epoetin-Beta별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• Epoetin-Beta
• Epoetin-Beta Biosimilars
• 세계의 말 헬스케어 시장 : Darbepoetin-Alfa별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• Darbepoetin-Alfa
• Darbepoetin-Alfa Biosimilars
• 세계의 말 헬스케어 시장 : 기타 제품별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• Peginesatide
• 기타 새로운 EPO 제품

제7장 지역별/국가별 분석

• 세계의 말 헬스케어 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 세계의 말 헬스케어 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 말 헬스케어 시장 : 경쟁 구도
• 말 헬스케어 시장 : 기업 개요
  • Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
  • Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 주요 기업 및 혁신 기업

• 3SBio Inc.
• Celltrion Inc.
• Intas Pharmaceuticals Ltd.
• Boehringer Ingelheim GmbH
• Dr. Reddy's Laboratories Ltd.
• Sun Pharmaceutical Industries Ltd.
• Reliance Life Sciences Pvt. Ltd.
• Biocon Limited
• Chugai Pharmaceutical Co.
• Kyowa Kirin Co. Ltd.
• Apotex Inc.
• CJ Healthcare Corp.
• STADA Arzneimittel AG
• Hospira Inc.
• Sandoz International GmbH

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

• 말 헬스케어 시장(2029년) : 새로운 기회를 제공하는 국가
• 말 헬스케어 시장(2029년) : 새로운 기회를 제공하는 부문
• 말 헬스케어 시장(2029년) : 성장 전략
  • 시장 동향에 근거한 전략
  • 경쟁 전략

제36장 부록

LSH

영문 목차

영문목차

Equine healthcare encompasses services and products aimed at treating horses to improve their quality of life, enhance animal food quality, and extend their lifespan. This includes veterinary services for horses used in racing, competitive riding, and leisure, covering routine care such as vaccinations, parasite control, dental care, grooming, hoof care, and protection from natural elements.

Equine healthcare primarily comprises drugs, vaccines, and medical feed additives as its main product types. Drugs, which are pharmacologically active substances, are administered to horses in the event of various diseases such as equine influenza, equine herpes virus, equine encephalomyelitis, West Nile virus, equine rabies, Potomac horse fever, and tetanus. These products are distributed through veterinary hospitals and clinics, retail pharmacies, and online pharmacies.

The equine healthcare market research report is one of a series of new reports from The Business Research Company that provides equine healthcare market statistics, including equine healthcare industry global market size, regional shares, competitors with an equine healthcare market share, detailed equine healthcare market segments, market trends and opportunities, and any further data you may need to thrive in the equine healthcare industry. This equine healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The equine healthcare market size has grown strongly in recent years. It will grow from $1.41 billion in 2024 to $1.49 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to equine aging population, preventive healthcare practices, equestrian sports and activities, rising awareness among owners, disease outbreaks and control.

The equine healthcare market size is expected to see strong growth in the next few years. It will grow to $1.91 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to genetic testing and personalized medicine, equine wellness programs, globalization of equine events, zoonotic disease preparedness, compliance with anti-doping regulations. Major trends in the forecast period include telemedicine and remote monitoring solutions, wearable technologies for horses, equine rehabilitation and physical therapy, equine dental care and dentistry services, herbal and alternative therapies.

The rising awareness of animal healthcare is expected to drive the growth of the equine healthcare market throughout the forecast period. Individuals are becoming increasingly conscious of the vital role animals play in the ecosystem, recognizing that animal health is essential not only for their own safety and well-being but also for that of humans. Diseases affecting animals can easily be transmitted to people, prompting governments and private organizations to invest in developing animal healthcare infrastructure across various countries. For instance, in February 2023, a survey by Euromonitor International Ltd., a UK-based data analytics and research firm, revealed that the frequency of daily or nearly daily pet treatment increased from 26% in 2021 to 29% in 2023. Consumers are prioritizing health over indulgence and are seeking nourishing and functional treats. Consequently, the growing awareness of animal healthcare will contribute to the market's expansion during the forecast period.

The equine healthcare market is expected to see an upswing in growth due to the increasing occurrences of zoonotic diseases. These infectious diseases, caused by pathogens such as viruses, bacteria, parasites, or fungi, have the potential to be transmitted between animals and humans. The expansion of the equine healthcare market is attributed to the heightened incidences of zoonotic diseases, prompting horse owners to prioritize preventive measures and healthcare for their animals. This trend is fueled by a heightened awareness of the risks associated with zoonotic transmission and the growing adoption of veterinary products and services. For instance, a report by the European Centre for Disease Prevention and Control, a government agency based in Sweden, revealed in December 2022 that Campylobacteriosis remains the most prevalent zoonosis, with reported cases rising to 127,840 in 2022. Chicken and turkey meat were identified as the primary sources of reported campylobacteriosis cases. Salmonella, the second-most common zoonosis, affected 60,050 individuals. Subsequent to Campylobacteriosis and Salmonellosis, Yersiniosis (6,789 cases), Shigatoxin-producing E. coli infections (6,084 cases), and Listeriosis (2,183 cases) were the most frequently reported zoonotic diseases. Consequently, the growth of the equine healthcare market is driven by the increasing incidences of zoonotic diseases.

Major companies in the equine healthcare market are concentrating on the development of preventative healthcare programs that offer predictable costs and stress the importance of early treatment. These programs are designed to assist horse owners in managing expenses and encourage the early diagnosis of health issues, thereby enhancing overall equine welfare. For example, in September 2024, Hook Norton Veterinary Group (HNVG Ltd) introduced the Equiplan Gold Health Care Scheme, which aims to improve veterinary services for equines. This scheme focuses on preventative healthcare, specifically targeting horse owners to ensure predictable veterinary costs and promote early intervention for minor issues before they escalate into emergencies. By fostering proactive care, the initiative aims to enhance the overall welfare of horses while reducing financial burdens for their owners.

Prominent companies in the equine healthcare market are actively engaged in the development of innovative products, including protein-based vaccines, to expand their customer bases, boost sales, and increase revenue. Protein-based vaccines typically involve utilizing specific proteins or antigens from the target pathogen to stimulate an immune response, avoiding the use of the live or killed form of the pathogen itself. An exemplary instance of this trend is seen in the actions of Dechra Pharmaceuticals PLC, a pharmaceutical company based in the UK. In August 2022, the company introduced the Strangvac vaccine tailored for horses and ponies. Strangvac is the only intramuscular vaccine designed to provide protection against strangles, a disease caused by the bacterium Streptococcus equi. Noteworthy for its composition, Strangvac incorporates recombinant proteins CCE, Eq85, and IdeE derived from Streptococcus equi. It features a Differentiating Infected from Vaccinated Animals (DIVA) capability. A distinct aspect of this vaccine is its formulation without live bacteria or bacterial DNA, ensuring that it does not yield positive results in culture or PCR tests. This unique feature enhances the vaccine's efficacy and safety in preventing strangles in horses.

In January 2024, Altano Group, a veterinary healthcare company based in Canada, acquired McKee Pownall Equine Services for an undisclosed sum. This acquisition underscores Altano's dedication to improving global equine healthcare by expanding its service offerings and promoting knowledge exchange within the equine veterinary sector. McKee Pownall Equine Services is a Canada-based firm that focuses on performance horse care, general wellness, and emergency veterinary services.

Major companies operating in the equine healthcare market include Merck & Co. Inc., Boehringer Ingelheim, Zoetis Inc., Patterson Companies Inc., Elanco, Idexx Laboratories Inc., Covetrus, Ceva Sante Animale, Virbac, Hilltop BioSciences Inc., Dechra Pharmaceuticals plc, CVS Group PLC, Vetoquinol, Purina Animal Nutrition LLC, Applied Biologics, SOUND, Hallmarq Veterinary Imaging, Ethos Veterinary Health LLC, Addison Biological Laboratory Inc., Animart LLC, Prisma Imaging, Bimini LLC, Equine Therapy Solutions

North America was the largest region in the equine healthcare market in 2024. The regions covered in the equine healthcare market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the equine healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The equine healthcare market includes revenues earned by entities by taking care of a horse for vaccinations, parasite control, and dental care. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Equine Healthcare Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on equine healthcare market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for equine healthcare ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The equine healthcare market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Drugs; Vaccines; Medical Feed Additives
• 2) By Disease: Equine Influenza; Equine Herpes virus; Equine Encephalomyelitis; West Nile Virus; Equine Rabies; Potomac Horse Fever; Tetanus
• 3) By Distribution: Veterinary Hospitals And Clinics; Retail Pharmacy; Online Pharmacies
• Subsegments:
• 1) By Drugs: Anti-Inflammatories; Antibiotics; Pain Management Medications; Anesthetics; Hormonal Therapies
• 2) By Vaccines: Core Vaccines; Risk-Based Vaccines; Combination Vaccines
• 3) By Medical Feed Additives: Nutritional Supplements; Probiotics And Prebiotics; Performance Enhancers; Medicated Feeds
• Companies Mentioned: Merck & Co. Inc.; Boehringer Ingelheim; Zoetis Inc.; Patterson Companies Inc.; Elanco
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Equine Healthcare Market Characteristics

3. Equine Healthcare Market Trends And Strategies

4. Equine Healthcare Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Equine Healthcare Growth Analysis And Strategic Analysis Framework

• 5.1. Global Equine Healthcare PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Equine Healthcare Market Growth Rate Analysis
• 5.4. Global Equine Healthcare Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Equine Healthcare Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Equine Healthcare Total Addressable Market (TAM)

6. Equine Healthcare Market Segmentation

• 6.1. Global Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Epoetin-alfa
• Epoetin-beta
• Darbepoetin-alfa
• Other Products
• 6.2. Global Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biologist
• Biosimilar
• 6.3. Global Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cancer
• Hematology
• Renal Diseases
• Neurology
• Other Applications
• 6.4. Global Equine Healthcare Market, Sub-Segmentation Of Epoetin-Alfa, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Epoetin-Alfa
• Epoetin-Alfa Biosimilars
• 6.5. Global Equine Healthcare Market, Sub-Segmentation Of Epoetin-Beta, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Epoetin-Beta
• Epoetin-Beta Biosimilars
• 6.6. Global Equine Healthcare Market, Sub-Segmentation Of Darbepoetin-Alfa, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Darbepoetin-Alfa
• Darbepoetin-Alfa Biosimilars
• 6.7. Global Equine Healthcare Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Peginesatide
• Other Novel EPO Products

7. Equine Healthcare Market Regional And Country Analysis

• 7.1. Global Equine Healthcare Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Equine Healthcare Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Equine Healthcare Market

• 8.1. Asia-Pacific Equine Healthcare Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Equine Healthcare Market

• 9.1. China Equine Healthcare Market Overview
• 9.2. China Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Equine Healthcare Market

• 10.1. India Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Equine Healthcare Market

• 11.1. Japan Equine Healthcare Market Overview
• 11.2. Japan Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Equine Healthcare Market

• 12.1. Australia Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Equine Healthcare Market

• 13.1. Indonesia Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Equine Healthcare Market

• 14.1. South Korea Equine Healthcare Market Overview
• 14.2. South Korea Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Equine Healthcare Market

• 15.1. Western Europe Equine Healthcare Market Overview
• 15.2. Western Europe Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Equine Healthcare Market

• 16.1. UK Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Equine Healthcare Market

• 17.1. Germany Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Equine Healthcare Market

• 18.1. France Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Equine Healthcare Market

• 19.1. Italy Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Equine Healthcare Market

• 20.1. Spain Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Equine Healthcare Market

• 21.1. Eastern Europe Equine Healthcare Market Overview
• 21.2. Eastern Europe Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Equine Healthcare Market

• 22.1. Russia Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Equine Healthcare Market

• 23.1. North America Equine Healthcare Market Overview
• 23.2. North America Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Equine Healthcare Market

• 24.1. USA Equine Healthcare Market Overview
• 24.2. USA Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Equine Healthcare Market

• 25.1. Canada Equine Healthcare Market Overview
• 25.2. Canada Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Equine Healthcare Market

• 26.1. South America Equine Healthcare Market Overview
• 26.2. South America Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Equine Healthcare Market

• 27.1. Brazil Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Equine Healthcare Market

• 28.1. Middle East Equine Healthcare Market Overview
• 28.2. Middle East Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Equine Healthcare Market

• 29.1. Africa Equine Healthcare Market Overview
• 29.2. Africa Equine Healthcare Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Equine Healthcare Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Equine Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Equine Healthcare Market Competitive Landscape And Company Profiles

• 30.1. Equine Healthcare Market Competitive Landscape
• 30.2. Equine Healthcare Market Company Profiles
  • 30.2.1. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Equine Healthcare Market Other Major And Innovative Companies

• 31.1. 3SBio Inc.
• 31.2. Celltrion Inc.
• 31.3. Intas Pharmaceuticals Ltd.
• 31.4. Boehringer Ingelheim GmbH
• 31.5. Dr. Reddy's Laboratories Ltd.
• 31.6. Sun Pharmaceutical Industries Ltd.
• 31.7. Reliance Life Sciences Pvt. Ltd.
• 31.8. Biocon Limited
• 31.9. Chugai Pharmaceutical Co.
• 31.10. Kyowa Kirin Co. Ltd.
• 31.11. Apotex Inc.
• 31.12. CJ Healthcare Corp.
• 31.13. STADA Arzneimittel AG
• 31.14. Hospira Inc.
• 31.15. Sandoz International GmbH

32. Global Equine Healthcare Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Equine Healthcare Market

34. Recent Developments In The Equine Healthcare Market

35. Equine Healthcare Market High Potential Countries, Segments and Strategies

• 35.1 Equine Healthcare Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Equine Healthcare Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Equine Healthcare Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료